Sell

GlaxoSmithKline Pharmaceuticals Ltd: Outlook & Valuation: We downgrade our revenue estimates for FY21E by 4.3% to Rs 34.5 bn and introduce our revenues for FY22E.

28-30% of revenue compared to last year in Q1FY21E and gradual recovery from Q2FY21E. As per the management, 60-65% of DLPL's total operating cost is fixed in nature and the new additional expense (cost of safety for...

We recommend a SELL on JUBILANT FOODWORKS with a Target Price of Rs 1,408 a downside of 7% from CMP of Rs 1,515 and Stop Loss Rs 1,568.

Shree Cement Limited provides building materials. The company manufactures and sells cement and cement products in India. The company currently operates with a total cement capacity of 44.4mpta of...

shocks, we build in weak collection trends and higher provisions on rural & retail business side. Against this backdrop, we incorporate subdued growth (4-12%), high 6.5% NPA translating into structurally lower RoEs of 7% by...

While concerns about the travel & transport vertical (<5% revenue share for tier-I India IT) are at the forefront, we believe retail the second largest vertical with 14% share will be the worst hit for India IT services.

30% in red zone) should further weigh down on asset quality and earnings over FY21-22. Consequently, GNPA & credit costs estimates stand marginally tweaked to (7-8% vs 7.5% earlier and 2.4%+ vs 2.3% earlier resp.) prompting to trim EPS estimates by 2-8% over FY21-22E. With return profile (RoE: 9%/RoA:1.2%) offering no respite, we reiterate REDUCE rating with SoTP...

CIPLA's Adj. Revenue was Rs43bn (PLe Rs39.9bn) flat YoY and growth of 2% QoQ while EBITDA declined 32% YoY and 10% QoQ to Rs5.6bn (PLe Rs5.3bn). Adj. EBITDA margin was 13% (PLe 13.2%) vs. 19.4% YoY and 14.7% QoQ. Domestic biz continued to lead for CIPLA with 12% YoY growth while export markets performance and remediation of Goa facility (costing Rs430-450mn i.e. 1% of revenue) impacted EBITDA margin (showing a decline of 200bps...

Accelya Solution (Accelya) reported poor results on profitability front. Revenues were flat at | 113.8 crore while EBITDA margins declined 336 bps QoQ to 36.5% leading to an overall decline of 8.1% QoQ in rupee terms. In addition, profit before tax declined 12.2% QoQ, 20.6% YoY to | 32.2 crore. PAT declined 12.4% QoQ, 10.6% YoY to | 23.7 crore. We believe the key reason for this poor profitability performance is the company's exposure to travel vertical (especially exposure to airlines) that has been severely impacted due to Covid-19 crisis. The company expects Q4FY20E (June...

Best case estimates peg lower double digit decline in FY20! Covid-19 is a black swan event, which has brought the entire economy to a standstill. It was a further blow to the automobile sector, which was already struggling with weak consumer sentiment with domestic sales volume down 18% YoY in FY20. With movement of people highly restricted as well as income levels taking a hit, car purchase as a discretionary spend is expected to take a backseat. A caveat, however, is the initial signs of people traversing from shared mobility/public transport to personal mobility. However, there...